• Phone30913383
1991 …2024

Research activity per year

Personal profile

Research areas

Clinical research in diabetic complications, main focus on diabetic nephropathy and cardiovascular disease

clinical trials, biomarker discovery with targeted and untargeted methods

metabolomics in relation to progresion of type 1 and type 2 diabetes, liver disease and diabetic complications

Main research areas

Diabetic nephropathy, cardiovascular disease, neuropathy, metabolomics

Current research

Focus on late diabetic complications,

biomarkers predicting risk for initiation or progression of complications,

clinical studies of interventions aiming at preventing or treating complications

improving understanding of pathophysiology of complications

Potential conflicts of interest

•consultancy and/or speaking fees (to institution) from AbbVie, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, MSD, Novo Nordisk and Sanofi Aventis
•research grants from AstraZeneca and Novo Nordisk
shares in Novo Nordisk

External positions

Steno Diabetes Center A/S

… → 2016

Professor in endocrinology with focus on vascular complications, University of Copenhagen


Dive into the research topics where Peter Rossing is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or